Evidence map›Paper›PMID 30287925›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosis.

Isabelle Schrauwen, Hanne Valgaeren, Laura Tomas-Roca, Manou Sommen, Umut Altunoglu, Mieke Wesdorp, Matthias Beyens, Erik Fransen, Abdul Nasir, Geert Vandeweyer and 21 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Heterozygous Nonsense Mutation in the Nuclear Transport FactorInternational journal of molecular sciences · 2026
    Article
  5. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  6. The Intricacies of Renal Phosphate Reabsorption-An Overview.International journal of molecular sciences · 2024
    Review
  7. Journal of medical genetics · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Insufficient evidence for a role of SERPINF1 in otosclerosis.Molecular genetics and genomics : MGG · 2019
    Article
  15. The CaBone · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 10 institutions in 7 countries.

Isabelle Schrauwen *Center of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Hanne Valgaeren *Center of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Laura Tomas-Roca *Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Manou Sommen *Center of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Umut Altunoglu *Medical Genetics Department, Istanbul Medical Faculty, Istanbul University, İstanbul, Turkey.
Mieke WesdorpDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Matthias BeyensCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Erik FransenCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Abdul NasirSynthetic Protein Engineering Lab (SPEL), Department of Molecular Science and Technology, Ajou University, Suwon, South Korea.
Geert VandeweyerCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Anne SchepersCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Malika RahmounDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Ellen van BeusekomDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Matt J HuentelmanNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Erwin OffeciersEuropean Institute for ORL, St-Augustinus Hospital Antwerp, Antwerp, Belgium.
Ingeborg DhoogheDepartment of Otolaryngology, Ghent University Hospital, Ghent, Belgium.
Alex HuberDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
Paul Van de HeyningDepartment of ORL and Head and Neck Surgery, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
Diego ZanettiDept. of Clinical Sciences and Community Health, Audiology Unit, University of Milan, I.R.C.C.S. Fondazione "Cà Granda", Osp.le Maggiore Policlinico, Milano, Italy.
Els M R De LeenheerDepartment of Otorhinolaryngology, Hearing & Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Christian GilissenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Alexander HoischenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Cor W CremersDepartment of Otorhinolaryngology, Hearing & Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Berit VerbistDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Arjan P M de BrouwerDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
George W PadbergDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Ronald PenningsDonders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Hülya KayseriliMedical Genetics Department, Koç University School of Medicine (KUSOM), İstanbul, Turkey.
Hannie Kremer *Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Guy Van Camp *Center of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium. guy.vancamp@uantwerpen.be.
Hans van Bokhoven *Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Hans.vanBokhoven@radboudumc.nl.
Radboud University Nijmegen · NLUniversity of Antwerp · BETranslational Genomics Research Institute · USAjou University · KRAntwerp University Hospital · BEGhent University Hospital · BEIstanbul University · TRKoç University · TRUniversity Hospital of Zurich · CHUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo characterize new molecular factors implicated in a hereditary congenital facial paresis (HCFP) family and otosclerosis.

methodsWe performed exome sequencing in a four-generation family presenting nonprogressive HCFP and mixed hearing loss (HL). MEPE was analyzed using either Sanger sequencing or molecular inversion probes combined with massive parallel sequencing in 89 otosclerosis families, 1604 unrelated affected subjects, and 1538 unscreened controls.

resultsExome sequencing in the HCFP family led to the identification of a rare segregating heterozygous frameshift variant p.(Gln425Lysfs*38) in MEPE. As the HL phenotype in this family resembled otosclerosis, we performed variant burden and variance components analyses in a large otosclerosis cohort and demonstrated that nonsense and frameshift MEPE variants were significantly enriched in affected subjects (p = 0.0006-0.0060).

conclusionMEPE exerts its function in bone homeostasis by two domains, an RGD and an acidic serine aspartate-rich MEPE-associated (ASARM) motif inhibiting respectively bone resorption and mineralization. All variants associated with otosclerosis are predicted to result in nonsense mediated decay or an ASARM-and-RGD-truncated MEPE. The HCFP variant is predicted to produce an ASARM-truncated MEPE with an intact RGD motif. This difference in effect on the protein corresponds with the presumed pathophysiology of both diseases, and provides a plausible molecular explanation for the distinct phenotypic outcome.

Indexed as

AdultBone and BonesExome SequencingExtracellular Matrix ProteinsFacial ParalysisFamilyFemaleGenetic Diseases, X-LinkedGenetic VariationGlycoproteinsHearing LossHeterozygoteHumansMaleOtosclerosisPedigreeExtracellular Matrix ProteinsGlycoproteinsMEPE protein, humanPhosphoproteinscraniofacial bone disorderhearing losshereditary congenital facial paresisMEPEotosclerosis

Identifiers

PMID30287925
OpenAlexW2894574137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.